You have 9 free searches left this month | for more free features.

SHP2

Showing 1 - 25 of 277

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Adelaide, South Australia, Australia
    Cancer Research SA
Aug 15, 2022

Non Small Cell Lung Cancer, Solid Tumor Trial in Fairfax (BBP-398 with nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • BBP-398 with nivolumab
  • Springdale, Arkansas
  • +6 more
Jan 27, 2023

Advanced Solid Tumor Trial in Changsha, Chengdu (ET0038)

Recruiting
  • Advanced Solid Tumor
  • Changsha, Hunan, China
  • +1 more
Apr 24, 2022

Advanced Solid Tumor, Advanced or Metastatic NSCLC Trial in Guanzhou, Chengdu (BBP-398)

Recruiting
  • Advanced Solid Tumor
  • Advanced or Metastatic Non-small Cell Lung Cancer
  • Guanzhou, Guangdong, China
  • +1 more
Nov 30, 2022

Solid Tumor, Unspecified, Adult Trial in United States (RLY-1971)

Completed
  • Solid Tumor, Unspecified, Adult
  • Lake Mary, Florida
  • +5 more
Jan 30, 2023

Hormonal Sensitivity in Noonan and LEOPARD Syndromes

Completed
  • Noonan Syndrome
  • LEOPARD Syndrome
    • Toulouse, France
      CIC de Toulouse- Unité pediatrique
    Aug 25, 2021

    Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Amsterdam (RMC-4630, LY3214996)

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • (no location specified)
    Mar 9, 2022

    NSCLC, Head Neck Cancer, Esophageal Cancer Trial in Beijing (JAB-3068)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Beijing, Beijing, China
    • +4 more
    Mar 11, 2022

    Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Puerto Rico, United States (HBI-2376)

    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Duarte, California
    • +11 more
    Aug 23, 2022

    Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura (TTP)
    • TAK-755
    • (no location specified)
    Feb 9, 2023

    Hunter Syndrome Trial in Canada, France (Idursulfase-IT, Elaprase)

    Not yet recruiting
    • Hunter Syndrome
    • Calgary, Alberta, Canada
    • +3 more
    Sep 4, 2023

    Advanced or Metastatic Solid Tumors Trial in Australia, United States (ERAS-601, Cetuximab)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • Sarasota, Florida
    • +8 more
    Feb 18, 2022

    Metachromatic Leukodystrophy (MLD) Trial in Worldwide (SHP611)

    Active, not recruiting
    • Metachromatic Leukodystrophy (MLD)
    • Torrance, California
    • +29 more
    Dec 13, 2022

    Cytomegalovirus (CMV) Trial in Miami (Digoxin, Maribavir, Dextromethorphan)

    Completed
    • Cytomegalovirus (CMV)
    • Miami, Florida
      Clinical Pharmacology of Miami, Inc.
    May 13, 2021

    NSCLC, Head Neck Cancer, Esophageal Cancer Trial in United States (JAB-3068)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Denver, Colorado
    • +3 more
    Mar 25, 2021

    Healthy Volunteers Trial in Knoxville (SHP681, Placebo)

    Completed
    • Healthy Volunteers
    • Knoxville, Tennessee
      New Orleans Center for Clinical Research
    Feb 8, 2021

    Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)

    Available
    • Hereditary Angioedema (HAE)
    • Angioedema
    • Lanadelumab 150 mg
    • Lanadelumab 300 mg
    • Scottsdale, Arizona
    • +19 more
    Sep 16, 2022

    Progressive Familial Intrahepatic Cholestasis, Alagille Syndrome, Cholestatic Liver Disease Trial in Worldwide (Maralixibat)

    Recruiting
    • Progressive Familial Intrahepatic Cholestasis
    • +2 more
    • Los Angeles, California
    • +13 more
    Jul 18, 2022

    Squamous Cell Carcinoma Trial in Stanford (Remetinostat)

    Terminated
    • Squamous Cell Carcinoma
    • Stanford, California
      Stanford Medical Center
    Apr 28, 2021

    Retinopathy of Prematurity (ROP), Intraventricular Hemorrhage, Bronchopulmonary Dysplasia Trial in Worldwide (SHP607)

    Active, not recruiting
    • Retinopathy of Prematurity (ROP)
    • +3 more
    • Mobile, Alabama
    • +50 more
    Mar 21, 2022

    Fabry Disease Trial in Worldwide (REPLAGAL)

    Recruiting
    • Fabry Disease
    • Calgary, Canada
    • +27 more
    Aug 8, 2022

    Advanced Solid Tumor Trial in Xi'an (HS-10381)

    Recruiting
    • Advanced Solid Tumor
    • Xi'an, Sichuan, China
      West China Hospital of Sichuan University
    Jul 4, 2022

    Thrombotic Thrombocytopenic Purpura (TTP) Trial in Worldwide (BAX930, Standard of care)

    Recruiting
    • Thrombotic Thrombocytopenic Purpura (TTP)
    • BAX930
    • Standard of care
    • Atlanta, Georgia
    • +29 more
    May 4, 2022

    Primary Sclerosing Cholangitis Trial in Worldwide (Volixibat, Placebo)

    Recruiting
    • Primary Sclerosing Cholangitis
    • Coronado, California
    • +36 more
    Jul 29, 2022

    Angioedema Trial in Worldwide (Lanadelumab, Placebo)

    Completed
    • Angioedema
    • Birmingham, Alabama
    • +44 more
    Oct 24, 2022